HopeStage
Back to all studies
Active Not RecruitingNCT05172271

Transcranial electrical stimulation for difficult-to-treat depression

About this titleRead the official source — NCT05172271
Device studyAges 25–64United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 25 years to 64 years.

What will I do during this study?

The protocol includes: Having magnetic resonance imaging (MRI) scans.

Listed locations
BethesdaSee all locations and recruitment
Participation duration
Up to 42 weeks

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 8, 2022
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
8
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Device
Intervention type
Device, Other
Locations
United States
Age range
From 25 Years to 64 Years
Official registry ID
NCT05172271
Official title
Show the full official title

A Feasibility Study of Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)

Recruitment & locations

Not recruiting

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Who can participate?

Listed age limits: 25 years to 64 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies